Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.
about
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaA single center clinical analysis of children with high-risk neuroblastoma.Intensification of therapy using hematopoietic stem-cell support for high-risk neuroblastoma.High-dose therapy with stem cell rescue for pediatric solid tumors: rationale and results.Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth.Locoregional tumor progression after radiation therapy influences overall survival in pediatric patients with neuroblastoma.The surgeon and the child with cancer: A report of the International Society of Pediatric Surgical Oncology (IPSO).Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience.Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology GroupA monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivityChemotherapeutic effect of calcidiol derivative B3CD in a neuroblastoma xenograft model.Novel synthetic monoketone transmute radiation-triggered NFκB-dependent TNFα cross-signaling feedback maintained NFκB and favors neuroblastoma regression.Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)Effect of indole ethyl isothiocyanates on proliferation, apoptosis, and MAPK signaling in neuroblastoma cell linesMurine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remissionAnti-proliferative and pro-apoptotic properties of 3-bromoacetoxy calcidiol in high-risk neuroblastoma.Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma.Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma.Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma.Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children's Research Hospital Experience.Successive double high-dose chemotherapy with peripheral blood stem cell rescue collected during a single leukapheresis round in patients with high-risk pediatric solid tumors: a pilot study in a single center.Frequency and proliferative response of circulating invariant natural killer T cells in pediatric patients with malignant solid tumors.
P2860
Q24186636-98CDDD16-2A14-453E-A896-073359433E2FQ24200296-BC83095C-862D-4218-B652-5F7611E69853Q33728327-DB7B1DA6-0D45-4D49-A135-B4E53277DD09Q33788210-0461F9D8-CCD3-4C07-9E74-1E1612626F79Q33788214-26085076-AD1C-4823-91A1-F4033F34B053Q33808326-2460F78C-5214-42FD-95F5-67FF8BE0FBDCQ33908476-92671C4A-0CF1-4974-9F55-2072DBE46608Q33936610-40D1DB88-4870-4FB8-8FAA-2789D0CCE499Q33964937-5E147313-0B31-415C-8029-3D6BAFF18BA6Q33999779-187421A0-DEE8-453F-8975-BBEC416BAB5FQ34038079-FBF3F776-6F87-4329-96E4-F71D4299CE49Q34505680-1FDE61B0-A05B-4743-A489-F81E2500610BQ34965143-F47ED850-6252-47CC-AE87-4526E316A55FQ36167173-6AB4D2DA-79E7-497C-B256-CA494CBA67E0Q36168388-6CE8C24A-F12A-44CD-AD3A-D895C3DAADC0Q36212437-D4D6E965-0545-4EAC-93B5-8755D341F3E7Q36845731-D78418FC-CDAE-47D5-822A-FE5B4ABB3256Q37718554-7B292E5D-6113-4641-BBB3-A7E5D46858AFQ38804821-1E094DE1-4E8D-4915-AF49-622037C8BC86Q39511962-E1B7E8C4-21D3-40F9-B90A-16BBAA963F1EQ41634067-887ED88C-FE1B-4A0D-AEB9-71E1829FDF48Q41644455-50FEEB5F-5A83-48B8-A578-AC411822E884Q43407337-666FC19E-0434-47F2-AB93-9687CAD6D8CFQ45948464-BCC235BD-DF55-4822-9187-0EBCA0E10C35Q46804043-0BC0D7BD-6DA5-4F31-A3F4-FFAE70990A15Q48350600-0A7D4742-EA8B-4122-AF0D-1D3DCE7AED26Q50091802-4E03CB8B-D73C-4797-A0AE-34DA6B5E1F90
P2860
Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Patterns of relapse after auto ...... rens Cancer Group pilot study.
@en
Patterns of relapse after auto ...... rens Cancer Group pilot study.
@nl
type
label
Patterns of relapse after auto ...... rens Cancer Group pilot study.
@en
Patterns of relapse after auto ...... rens Cancer Group pilot study.
@nl
prefLabel
Patterns of relapse after auto ...... rens Cancer Group pilot study.
@en
Patterns of relapse after auto ...... rens Cancer Group pilot study.
@nl
P2093
P1476
Patterns of relapse after auto ...... drens Cancer Group pilot study
@en
P2093
J B Atkinson
K K Matthay
R C Seeger
P304
P356
10.1200/JCO.1993.11.11.2226
P407
P50
P577
1993-11-01T00:00:00Z